Stepanenko, Roman Leonidovich and Mohammed, Ali and Stepanenko, Viktor Ivanovich and Konovalova, Tetiana and Tsekhmister, Yaroslav Volodymyrovych (2021) Indicators of the Spectrum of Lipids of the Water-Lipid Mantle of the Skin Before and after Pathogenetically Sound Therapy of Patients with Psoriasis. Journal of Pharmaceutical Research International, 33 (44B). pp. 279-284. ISSN 2456-9119
3461-Article Text-5205-1-10-20221006.pdf - Published Version
Download (250kB)
Abstract
Aim: The aim of the study is to analyze the features of the spectrum of lipids of the water-lipid mantle of the skin before and after pathogenetically sound therapy of patients with psoriasis.
Methods: Comparative evaluation of the therapeutic efficacy of monotherapy with the immunobiological drug Humir (adalimumab), as well as its combination with a non-hormonal drug based on natural components Psori Active (cream) in the examined patients with psoriasis vulgaris was performed according to the dynamics of regression of dermatoses clinical manifestations erythema, infiltration, peeling of the skin psoriatic rash, changes in the index PASI, PGA, BSA.
Results: The study involved 137 patients. Changes in the level of other components of the lipid spectrum of the water-lipid mantle of the skin, in particular phospholipids, cholesterol and cholesterol esters in patients of the first observation group changed insignificantly compared to their values before treatment. When comparing the normalization of the level of the studied spectrum of lipids of the water-lipid mantle of the skin in patients of the second group with different seasonal types (autumn-winter, spring-summer, off-season) and previously diagnosed with varying severity treatment, no statistically significant differences were found between seasonal types of dermatosis.
Conclusion: Analysis of the results of clinical follow-up of the examined patients with psoriasis of the first and second groups after completion of treatment and achieving clinical clinical remission indicates significant benefits of systemic immunobiological therapy in combination with topical therapy with Psori Active.
Item Type: | Article |
---|---|
Subjects: | Science Repository > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 25 Apr 2023 04:22 |
Last Modified: | 07 Feb 2024 04:19 |
URI: | http://research.manuscritpub.com/id/eprint/1751 |